AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+6.3%
5Y CAGR+7.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+6.3%/yr
vs +15.6%/yr prior
5Y CAGR
+7.8%/yr
Consistent
Acceleration
-9.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $62.39B | +12.1% |
| 2024 | $55.66B | +8.9% |
| 2023 | $51.09B | -1.7% |
| 2022 | $52.00B | +0.3% |
| 2021 | $51.82B | +20.6% |
| 2020 | $42.95B | +19.1% |
| 2019 | $36.07B | +23.9% |
| 2018 | $29.11B | +21.8% |
| 2017 | $23.90B | +18.6% |
| 2016 | $20.16B | - |